- Recent Funding
- Investors
- Alexandria Real Estate Equities
Alexandria Real Estate Equities portfolio
Alexandria Real Estate Equities has 1 portfolio company on record at Recent Funding, with 1 investment in the last 12 months.
About this page
Its most recent investment on record is Mediar Therapeutics's $76M Series B+ round in January 2026, alongside Longwood Fund, Amplitude Venture Capital, Intermediate Capital Group and 1 other. That company is in Health and bio.
What Alexandria Real Estate Equities invests in
- Health and bio · 1 · 100%
How Alexandria Real Estate Equities invests
| Stage | Deals | Capital in rounds |
|---|---|---|
| Series B+ | 1 100% | $76M |
Alexandria Real Estate Equities portfolio companies
MMediar Therapeutics$76MSeries B+ · Jan 2026
| Company | Round with Alexandria Real Estate Equities | Total raised | Latest raise |
|---|---|---|---|
Health and bio |
Series B+ · $76M | $181M | Jan 7, 2026 Series B+ |
Most frequent co-investors
LLongwood Fund1 shared round · last Jan 7, 2026
AAsahi Kasei Pharma1 shared round · last Jan 7, 2026
IIntermediate Capital Group1 shared round · last Jan 7, 2026
AAmplitude Venture Capital1 shared round · last Jan 7, 2026
Similar investors
IIzou Partners2 companies · 2 deals in 12 mo
- TThe Ljungstrom Family Office2 companies · 2 deals in 12 mo
OO'Shaughnessy Ventures3 companies · 1 deal in 12 mo
SSide Stage Ventures3 companies
AAble Partners4 companies · 1 deal in 12 mo
BBdc Thrive venture5 companies · 3 deals in 12 mo
Investors whose portfolios on Recent Funding center on the same category (Health and bio).
How this is counted
Share is of the 1 round on Recent Funding that name Alexandria Real Estate Equities. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.
Portfolio companies are the companies on Recent Funding with a round that lists Alexandria Real Estate Equities, which is a subset of its real portfolio. API: /api/v1/investors/alexandria-real-estate-equities (get a free API key). More: the most active VC firms and new venture capital funds.